<DOC>
	<DOCNO>NCT02492230</DOCNO>
	<brief_summary>The objective Left atrial appendage closure compare standard antiplatelet therapy patient AF underwent percutaneous coronary intervention ( LLA-PCI ) study evaluate safety efficacy implantation leave atrial appendage closure compare standard antiplatelet therapy prevention thromboembolic event stent thrombosis subject AF underwent PCI .</brief_summary>
	<brief_title>Left Atrial Appendage Closure Compared Standard Antiplatelet Therapy Patients With AF Who Underwent PCI</brief_title>
	<detailed_description>This prospective randomized ( 1:1 ) open label pilot study . Patients unstable angina non-ST-elevation ACS history AF include study . After PCI DES implantation TEE perform assess LAA anatomy size eligible leave atrial appendage closure device implantation . After screen patient randomize two group . The first ( control ) group receive standard antiplatelet anticoagulation therapy accord guideline ( 2 ) , second group patient undergo leave atrial appendage closure device implantation . After PCI first group take Triple therapy ( warfarin + clopidogrel+aspirin ) 45 day combination warfarin+clopidogrel 6 month procedure warfarin . The second group take Triple therapy ( warfarin+clopidogrel+aspirin ) 45 day follow PCI control TEE , warfarin discontinue . Then patient second group take DAPT combination ( clopidogrel+aspirin ) 6 month procedure aspirin . Patients follow 45 day , every 3 month 12 month follow ( Figure 1 ) . At follow-up visit data regard clinical event healthcare utilization collect .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Inclusion criterion : age &gt; 18 year old Acute coronary syndrome without ST elevation unstable angina 2 week enrolment Successful PCI procedure DES History atrial fibrillation ( paroxysmal , persistent permanent ) ECG documentation within previous 12 month CHA2DS2VASC ≥ 2 HASBLED ≥ 3 LAA eligible leave atrial appendage closure device implantation ( TEE data ) Exclusion criterion : age &lt; 18 &gt; 80 year old INR &gt; 3 recurrent myocardial infarction myocardial infarction ST elevation EF &lt; 50 % severe comorbidities Cardiogenic shock ( within 72 hour randomization ) , define need intraaortic balloon support requirement intravenous inotropic support . anemia &lt; 100 g/l uncontrolled hypertension thrombocytopenia oncology obesity , BMI &gt; 40 LAA thrombosis Women childbearing potential ( unless postmenopausal surgically sterile )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>